Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00130416 · ClinicalTrials.gov registry record · NA
Improving Chronic Disease Care With PatientSite
A NA study, sponsored by Robert Wood Johnson Foundation.
- Completed
- Registry status
- NA
- Development phase
- 750
- Enrollment target
NCT00130416: Completed NA study, sponsored by Robert Wood Johnson Foundation.
NCT00130416 is a NA study that has completed, run by Robert Wood Johnson Foundation. The registered enrollment target is 750 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00130416, a NA study, has completed, sponsored by Robert Wood Johnson Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 750 participants
- Enrollment target
Study Summary
The overall goal of this randomized, controlled trial is to test whether educational interventions - directed toward empowering patients and delivered via the Beth Israel Deaconess Medical Center (BIDMC's) secure patient Internet portal PatientSite - can improve the outcomes and satisfaction with care of adult primary care patients with 3 common conditions: chronic pain, depression, and progressive difficulty walking.
Interventions
- BEHAVIORAL E-mail coaching to improve patient communication with doctor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2004-09 |
| Est. Completion | 2007-12 |
| Phase | NA |
What the finished NCT00130416 record still lists
NCT00130416 is an interventional study that assigns participants to a tested intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 1 intervention - of which E-mail coaching to improve patient communication with doctor is the first listed.
NCT00130416 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00130416 about?
NCT00130416 is a clinical study titled "Improving Chronic Disease Care With PatientSite". The overall goal of this randomized, controlled trial is to test whether educational interventions - directed toward empowering patients and delivered via the Beth Israel Deaconess Medical Center (BIDMC's) secure patient Internet portal PatientSite - can improve the outcomes and satisfaction with ca...
What is the current status of trial NCT00130416?
This trial is currently completed. It is a NA study. The enrollment target is 750 participants. The study started on 2004-09. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00130416?
The interventions under investigation include: E-mail coaching to improve patient communication with doctor (BEHAVIORAL).
Who is sponsoring clinical trial NCT00130416?
This trial is sponsored by Robert Wood Johnson Foundation, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00130416's enrollment target sits among peer trials
750 145th of 2000 higher than 1,856 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02087852 · 750 participants
Kidney Cancer DNA Registry
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
- NCT03126916 · 750 participants · Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia